First, the shape of it
The most recent filing shows a headline loss bigger than the company earns in a full year, sitting beside an operating margin that is among the strongest in legal cannabis. Those two readings come from the same quarter. The headline loss is an accounting event; the margin is a cash reality. Which one a reader focuses on determines almost everything about how this business looks right now.
Two numbers that should not coexist
In the second quarter of 2026, Trulieve reported a GAAP net loss of $406 million. In the same quarter, it posted a gross margin of 60%, meaning six dollars of every ten in sales stayed after the cost of growing and selling the product. A business losing that much and keeping sixty cents of every revenue dollar is not a contradiction, but it does require an explanation.
Almost all of that loss, $403 million of it, came from a single structural event: Trulieve deconsolidated its Harvest operations on June 3, 2026. Deconsolidation is an accounting term for removing a subsidiary from the parent’s books, and when the assets leave, any gap between what they were carried at and what they are now worth gets recorded as a loss in one lump. Think of it as a write-down taken all at once rather than spread across years. Strip that out, and adjusted net income for the quarter was $20 million, or $0.11 per share. The math and the mood, meaning what the filed fundamentals show versus what the headline number implies, are unusually far apart here.
What the Harvest split actually means
Trulieve built itself into the largest medical cannabis operator in Florida, then spent several years buying its way into other states through the Harvest acquisition. That expansion pushed revenue well past a billion dollars but also dragged margins and produced four consecutive years of GAAP losses. The Harvest deconsolidation reverses that logic: Trulieve is separating its medical-only operations from its mixed-use markets, partly to qualify for DEA registration under the federal rescheduling of cannabis from Schedule I to Schedule III that took effect in April 2026, according to Investing.com. Rescheduling matters because it removes the Section 280E tax rule, which had barred cannabis companies from deducting ordinary business expenses, a burden that cost the industry hundreds of millions annually.
The corporate restructuring also cleared the path for Trulieve to complete its redomicile from British Columbia to Delaware, effective August 11, 2026, and list on the New York Stock Exchange under the ticker TRLV. Moving from a Canadian provincial charter to a Delaware corporation is the legal equivalent of moving from a side street to a main road: it opens the company to a much larger pool of institutional investors who cannot or will not hold foreign-domiciled shares.
The revenue line tells a quieter story
Beneath the restructuring noise, the revenue trend is flat. The 10-K for fiscal year 2025 shows full-year revenue essentially unchanged from the prior year, which was itself only modestly above the year before that. A business growing at roughly zero is not compounding; it is holding position. For a company priced at two times sales, our data shows that multiple sits at the 80th percentile of its own history, meaning the market is paying more relative to revenue than it has in eight of the last ten comparable periods. That is a lot of confidence to place in a flat top line.
The adjusted EBITDA margin of 36% for Q2 2026 is the number that complicates the pessimistic read. EBITDA, earnings before interest, taxes, depreciation, and amortization, strips out non-cash charges and financing costs to show what the core operation produces. At more than a third of each revenue dollar, Trulieve is keeping genuinely more than most retailers, cannabis or otherwise. Whether that translates to durable profit depends on how the 280E relief flows through to taxable income over the rest of 2026, and the data cannot yet confirm that trajectory.
The Florida lawsuit and what it signals
Trulieve filed a lawsuit in March 2026 challenging a Florida Department of Health rule that sharply restricts cannabis advertising, including digital marketing, according to Investing.com. Florida is Trulieve’s home market and the foundation of its margins. A company that controls its home market well enough to generate industry-leading gross margins does not sue its regulator unless the rule threatens something real. The outcome of that case is unresolved, and the dossier does not contain enough detail to quantify the revenue at risk. That uncertainty is worth naming plainly.
Reading the numbers
- Q2 2026 GAAP net loss: $406 million ($2.10 per share). What it is: the total loss reported under standard accounting rules. What it means here: $403 million of this is a one-time accounting charge from removing Harvest from the consolidated books, not cash leaving the business. Everyday version: a household that sells a car for less than it paid records a “loss” on paper, but its monthly bills do not change.
- Q2 2026 gross margin: 60%. What it is: the share of each revenue dollar left after the direct cost of producing and selling the product. What it means here: Trulieve keeps sixty cents before paying rent, salaries, interest, and taxes. Everyday version: a bakery that charges $10 for a loaf and spends $4 on flour, labor, and packaging keeps $6 gross, then pays the landlord from that $6.
- Q2 2026 adjusted EBITDA: $98 million, 36% of revenue. What it is: operating profit with non-cash and financing items added back. What it means here: the core cannabis operation generated nearly $100 million in a single quarter before interest and depreciation. Everyday version: a rental property that collects $3,600 a month and costs $1,300 in maintenance and taxes “earns” $2,300 before the mortgage payment, which is the EBITDA equivalent.
- Price-to-sales multiple: 2.0, 80th percentile of own history (our data). What it is: the market price divided by annual revenue, a way to see how much investors are paying per dollar of sales. What it means here: the stock is priced more richly relative to its own revenue than it has been in most of its history, even as that revenue is flat. Everyday version: paying $200,000 for a rental property that earns $100,000 a year is a different bet than paying $130,000 for the same income.
Sources
- 10-Q for quarter ended June 30, 2026 (SEC EDGAR)
- Trulieve Q2 2026 earnings release, August 7, 2026
- Investing.com: Trulieve Q2 2026 slides, NYSE debut follows major restructuring
- Investing.com: Investors brace for Trulieve earnings amid rescheduling gains
- 10-K for fiscal year ended December 31, 2025 (SEC EDGAR)
- 10-K for fiscal year ended December 31, 2024 (SEC EDGAR)
